Skip to main content
. 2023 Mar 20:1–12. Online ahead of print. doi: 10.1007/s11136-023-03390-5

Table 3.

Known Groups Analysis Results for the Patient-Reported Frailty Phenotype (PRFP)

Frail Pre-Frail Fit
Age, y N = 990 N = 1209 N = 2729
  ≤ 75

859

(86.8%)

1036

(85.7%)

2439

(89.4%)

 76–80

97

(9.9%)

131

(10.8%)

207

(7.6%)

  > 80

34

(3.4%)

42

(3.5%)

83

(3%)

Charlson Comorbidity Index N = 990 N = 1209 N = 2729
 CCI ≤ 1 807 (81.5%)

983

(81.3%)

2351 (86.1%)
 CCI ≥ 2

183

(18.5%)

226

(18.7%)

378 (13.9%)
EQ-5D—Mobility N = 599 N = 677 N = 1478
 No problems in walking about

74

(12.4%)

207

(30.6%)

1016

(68.7%)

 Any level of problem in walking about

525

(87.6%)

470

(69.4%)

462

(31.3%)

EQ-5D—Self care N = 599 N = 676 N = 1478
 No problems in washing/dressing

274

(45.5%)

489

(72.3%)

1371

(92.8%)

 Any level of problem in washing/dressing

325

(54.3%)

187

(27.7%)

107

(7.2%)

EQ-5D—Usual activities N = 598 N = 676 N = 1478
 No problems in doing usual activities

42

(7%)

161

(23.8%)

989

(66.9%)

 Any level of problem in doing usual activities

556

(93%)

515

(76.2%)

489

(33.1%)

One of the six trials which incorporated the EQ-5D used the 3-Level version while the other five used the 5-Level version. Responses to the 3-Level version were dichotomized for the purposes of this Known Groups Analysis as ‘No problem’ vs. ‘Some problem’/‘Unable to…’, while responses to the 5-Level version were dichotomized as ‘No problem’ vs. ‘Slight’/‘Moderate’/‘Severe’/‘Unable to…’

All differences were statistically significant, p < 0.05, EQ-5D: EuroQol-5 Dimension